ATM and cancer: Furthermore, Salmonella typhi isolates presented high resistance rates in cancer patients compared to noncancer patients at COL (69.23% versus 0.00%), NIT (76.92% versus 0.00%), ATM (53.82% versus 20.00%), and CXM (100% versus 60.00%) (Table 5).